Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Coherus Bio (NQ: CHRS ) 0.7230 -0.0220 (-2.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Coherus Bio < Previous 1 2 3 4 5 6 7 8 9 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday October 30, 2023 It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session October 27, 2023 Via Benzinga Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) October 27, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Analyst Expectations for Coherus BioSciences's Future October 23, 2023 Via Benzinga 4 Analysts Have This to Say About Coherus BioSciences September 26, 2023 Via Benzinga Why Coherus BioSciences Stock Popped Today August 03, 2023 The immuno-oncology leader delivered a strong second quarter. Via The Motley Fool Analyst Ratings for Coherus BioSciences August 03, 2023 Via Benzinga Coherus BioSciences Announces New Employment Inducement Grants October 24, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics October 14, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Why Coherus BioSciences Stock Popped Today October 05, 2023 Coherus resubmitted a license application for a key product today. Here's what investors need to know. Via The Motley Fool Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™ October 05, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Earnings Preview For Coherus BioSciences August 01, 2023 Via Benzinga CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch October 04, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day October 02, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Announces Three Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) September 27, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients September 25, 2023 The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's (NASDAQ: CHRS) on-body injector (OBI) presentation of... Via Benzinga Exposures Product Safety Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session September 25, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. Via Benzinga FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections September 25, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus BioSciences Announces New Employment Inducement Grants September 22, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Completes Surface Oncology Acquisition September 08, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Why Coherus BioSciences Stock Was Plunging This Week September 08, 2023 The "index effect" is real, although typically not long-lasting. Via The Motley Fool Airbnb, Blackstone Rise On News They'll Join S&P 500 Index September 02, 2023 ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. Via Investor's Business Daily Topics Stocks Exposures US Equities Coherus BioSciences to Participate at Upcoming September Investor Conferences September 01, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences August 31, 2023 Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting From Surface Oncology, Inc. Via GlobeNewswire Coherus BioSciences Announces New Employment Inducement Grants August 22, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session August 03, 2023 Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60. Via Benzinga Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday August 03, 2023 U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 02, 2023 Via Benzinga Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights August 02, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023 July 26, 2023 From Coherus BioSciences, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
